ARK Investment Management - CHEMOMAB THERAPEUTICS LTD ownership

CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 14 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARK Investment Management ownership history of CHEMOMAB THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$4,000
-99.8%
792
-99.7%
0.00%
-100.0%
Q4 2021$1,844,000
-7.8%
267,292
+48.1%
0.01%
+20.0%
Q3 2021$2,000,000180,5230.01%
Other shareholders
CHEMOMAB THERAPEUTICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Orbimed Advisors 2,241,274$2,005,9400.04%
Ikarian Capital, LLC 213,392$190,9860.02%
BOOTHBAY FUND MANAGEMENT, LLC 26,529$23,7430.00%
KESTRA PRIVATE WEALTH SERVICES, LLC 31,241$27,9610.00%
Qube Research & Technologies Ltd 44$390.00%
Moser Wealth Advisors, LLC 500$4480.00%
Newbridge Financial Services Group, Inc. 1,100$9850.00%
UBS Group AG 141$1260.00%
RHUMBLINE ADVISERS 2,843$2,5420.00%
OSAIC HOLDINGS, INC. 1,775$1,5870.00%
View complete list of CHEMOMAB THERAPEUTICS LTD shareholders